TPST Total Utang marang Modal Tempest Tx

TPST (Tempest Therapeutics, Inc.) - tandha merek perusahaan

The current market quotes for Tempest Therapeutics (TPST) visualized below demonstrate financial resilience amid growing demand for drugs targeting solid tumors and liver cancer. The individual debt-to-equity ratio stands at 0.00. Tempest Therapeutics (TPST) develops small molecules for immune management in oncology, leveraging a powerful scientific resource. Simultaneously, the business is implementing environmental filters and conserving water in its laboratories.

Rasio Utang marang Ekuitas: tempesttx.com (TPST) kanggo 04.07.2022 - 28.10.2026

Rincian metrik komprehensif lan analitis Tempest Therapeutics Corp (TPST)

- rega lan prakiraan konsensus rega:
Rega saham Tempest Therapeutics, Inc.|TPST - Target konsensus
- data kapitalisasi pasar:
Kapitalisasi pasar Tempest Therapeutics|TPST - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Tempest Therapeutics|TPST - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku tempesttx.com|TPST - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Tempest Therapeutics|TPST - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Tempest Therapeutics|TPST - Kewajiban utang agregat|Utang marang nilai buku Tempest Therapeutics|TPST - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Tempest Therapeutics
Analisis komprehensif perusahaan:TPST - Tempest Therapeutics, Inc.
Sampel barang Tempest Therapeutics

For Tempest Therapeutics (TPST), whose model relies on costly oncology R&D without current revenue, the debt-to-equity ratio chart reflects the funding stability of its pipeline. This ratio compares total liabilities to net asset value, determining the degree of dependence on borrowed funds and the risk of capital degradation amid price volatility or changes in Fed rates.

Pesaing utama

Total Utang marang Modal ONC|Rasio Total Utang marang Ekuitas Halozyme Therapeutics, Inc.|Total Utang marang Modal RVMD|Total Utang marang Modal AAPG (Ascentage Pharma Corp)|CGON - Utang marang Ekuitas|Rasio Utang marang Ekuitas urogen.com URGN|BCAX: Total Utang marang Modal|PSNL - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ERAS|DCTH (Delcath Corp) - Utang marang Modal|YMAB - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi aurabiosciences.com (AURA)|Candel Therapeutics (CADL) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Accuray Inc (ARAY)|SELLAS Life Sciences Group - Total Utang marang Modal|ACTU - Rasio Total Utang marang Ekuitas|Citius Oncology, Inc. - Rasio Total Utang marang Ekuitas|HURA: Total Utang marang Modal|Utang marang Ekuitas Protara Therapeutics, Inc. TARA|Fate Therapeutics Inc (FATE) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal WHWK (Aadi Bioscience, Inc.)|Utang marang Modal TScan (TCRX)|Rasio Total Utang marang Ekuitas Champions Oncology|Utang Agregat marang Modal xbiotech.com (XBIT)|CVM: Total Utang marang Modal|OS Therapies Inc. - Utang marang Modal|RADX: Utang marang Ekuitas|ARTV: Rasio Total Utang marang Ekuitas|Utang marang Ekuitas adlainortye.com (ANL)|verupharma.com (VERU) - Utang Agregat marang Ekuitas|Total Utang marang Modal XLO (Xilio Therapeutics Inc)|Utang marang Modal RENB|MURA (Mural Oncology plc) - Utang marang Ekuitas|Koefisien Total Utang marang Modal kairospharma.com KAPA|Rasio Total Utang marang Ekuitas OnKure Therapeutics (OKUR)|GDTC - Utang Agregat marang Modal|Rasio Total Utang marang Ekuitas Curis Corp (CRIS)|Apollomics, Inc. (APLM) - Rasio Kabeh Utang marang Dana Pribadi|THAR - Rasio Total Utang marang Ekuitas|Advanced Biomed (ADVB) - Utang Agregat marang Modal|GNPX - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Calidi Bio|Sunshine Biopharma, Inc. - Total Utang marang Modal|Utang marang Modal XBIO (xeneticbio.com)|Utang marang Ekuitas Salarius|Rasio Kabeh Utang marang Dana Pribadi Kitov Pharma PPBT|AON - Total Utang marang Modal|BGNE: Total Utang marang Modal|Utang marang Ekuitas Checkpoint Therapeutics, Inc. (CKPT)|elevationoncology.com (ELEV) - Utang Agregat marang Ekuitas|Total Utang marang Modal ICAD (iCAD Inc.)|Utang marang Modal Ikena (IKNA)|Rasio Total Utang marang Ekuitas NTBL|Total Utang marang Modal viracta.com VIRX|Rasio Total Utang marang Ekuitas MorphoSys (MOR)|Utang Agregat marang Modal NAYA Biosciences Inc NAYA|Total Utang marang Modal AAPGV (Ascentage Pharma Group Ltd)